Your browser doesn't support javascript.
loading
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.
Kruse, Niels; Persson, Staffan; Alcolea, Daniel; Bahl, Justyna M C; Baldeiras, Ines; Capello, Elisabetta; Chiasserini, Davide; Bocchio Chiavetto, Luisella; Emersic, Andreja; Engelborghs, Sebastiaan; Eren, Erden; Fladby, Tormod; Frisoni, Giovanni; García-Ayllón, María-Salud; Genc, Sermin; Gkatzima, Olymbia; Heegaard, Niels H H; Janeiro, André M; Kovácech, Branislav; Kuiperij, H Bea; Leitão, Maria J; Lleó, Alberto; Martins, Madalena; Matos, Mafalda; Mollergard, Hanne M; Nobili, Flavio; Öhrfelt, Annika; Parnetti, Lucilla; de Oliveira, Catarina Resende; Rot, Uros; Sáez-Valero, Javier; Struyfs, Hanne; Tanassi, Julia T; Taylor, Peggy; Tsolaki, Magda; Vanmechelen, Eugeen; Verbeek, Marcel M; Zilka, Norbert; Blennow, Kaj; Zetterberg, Henrik; Mollenhauer, Brit.
Afiliación
  • Kruse N; Department of Neuropathology, University Medical Center, Göttingen, Germany. Electronic address: n.kruse@med.uni-goettingen.de.
  • Persson S; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Alcolea D; Department of Neurology, Institut Investigacions Biomediques, Hospital de Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain.
  • Bahl JM; Department of Autoimmunology & Biomarkers, Statens Serum Institut, Copenhagen S, Denmark.
  • Baldeiras I; Neurochemistry Laboratory, Department of Neurology, Faculty of Medicine, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
  • Capello E; Department of Neuroscience (DINOGMI), Clinical Neurology Unit, Genoa, Italy.
  • Chiasserini D; Centre for Memory Disturbances and Alzheimer's Centre-Laboratory of Clinical Neurochemistry, Department of Medicine, Section of Neurology, University of Perugia, Perugia, Italy.
  • Bocchio Chiavetto L; Neuropsychopharmacology Unit, IRCCS Cento S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; Faculty of Psychology, eCampus University, Novedrate (Como), Italy.
  • Emersic A; Department of Neurology, University Medical Centre, Ljubljana, Slovenia.
  • Engelborghs S; Reference Centre for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Eren E; Department of Neuroscience, Health Science Institute, Dokuz Eylül University, Izmir, Turkey.
  • Fladby T; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Frisoni G; Laboratory of Alzheimer´s Neuroimaging and Epidemiology, IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; Departments of Psychiatry and Internal Medicine, University Hospitals and University of Geneva, Geneva, Switzerland.
  • García-Ayllón MS; Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain; Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Sant Joan d´Alcant, Spain.
  • Genc S; Department of Neuroscience, Health Science Institute, Dokuz Eylül University, Izmir, Turkey.
  • Gkatzima O; 3rd Neurology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Heegaard NH; Department of Autoimmunology & Biomarkers, Statens Serum Institut, Copenhagen S, Denmark; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense C, Denmark.
  • Janeiro AM; Genomed, Diagnósticos de Medicina Molecular, Instituto de Medicina Molecular, Edificio Egas Moniz, Lisbon, Portugal.
  • Kovácech B; Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Kuiperij HB; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Leitão MJ; Neurochemistry Laboratory, Department of Neurology, Faculty of Medicine, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
  • Lleó A; Department of Neurology, Institut Investigacions Biomediques, Hospital de Sant Pau, Barcelona, Spain; Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain.
  • Martins M; Instituto de Medicina Molecular, Edificio Egas Moniz, Lisbon, Portugal; Instituto Gulbenkian de Ciência, Oeiras, Portugal.
  • Matos M; Instituto de Medicina Molecular, Edificio Egas Moniz, Lisbon, Portugal.
  • Mollergard HM; Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
  • Nobili F; Department of Neuroscience (DINOGMI), Clinical Neurology Unit, Genoa, Italy.
  • Öhrfelt A; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Parnetti L; Centre for Memory Disturbances and Alzheimer's Centre-Laboratory of Clinical Neurochemistry, Department of Medicine, Section of Neurology, University of Perugia, Perugia, Italy.
  • de Oliveira CR; Neurochemistry Laboratory, Department of Neurology, Faculty of Medicine, CHUC-Centro Hospitalar e Universitário de Coimbra, CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
  • Rot U; Department of Neurology, University Medical Centre, Ljubljana, Slovenia.
  • Sáez-Valero J; Centro de Investigación Biomédica en Red en enfermedades Neurodegenerativas-CIBERNED, Madrid, Spain; Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-CSIC, Sant Joan d´Alcant, Spain.
  • Struyfs H; Reference Centre for Biological Markers of Dementia (BIODEM), Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Tanassi JT; Department of Autoimmunology & Biomarkers, Statens Serum Institut, Copenhagen S, Denmark.
  • Taylor P; BioLegend, Inc., Dedham, MA, USA.
  • Tsolaki M; 3rd Neurology Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Vanmechelen E; ADx NeuroSciences NV, Gent, Belgium.
  • Verbeek MM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Zilka N; Institute of Neuroimmunology, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Blennow K; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Zetterberg H; Clinical Neurochemistry Laboratory, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Lond
  • Mollenhauer B; Department of Neuropathology, University Medical Center, Göttingen, Germany; Paracelsus-Elena-Klinik, Kassel, Germany; Department of Neurosurgery, University Medical Center, Göttingen, Germany.
Neurobiol Aging ; 36(9): 2587-96, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26093515
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Enfermedades Neurodegenerativas / Alfa-Sinucleína Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Female / Humans / Male País/Región como asunto: America do norte / Europa Idioma: En Revista: Neurobiol Aging Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Enfermedades Neurodegenerativas / Alfa-Sinucleína Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Female / Humans / Male País/Región como asunto: America do norte / Europa Idioma: En Revista: Neurobiol Aging Año: 2015 Tipo del documento: Article